| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 5.38e-05 | 3 | 88 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 5.38e-05 | 3 | 88 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 5.38e-05 | 3 | 88 | 2 | GO:1902407 | |
| Domain | RasGAP_C | 6.56e-05 | 3 | 88 | 2 | IPR000593 | |
| Domain | RasGAP_C | 6.56e-05 | 3 | 88 | 2 | PF03836 | |
| Domain | Anion_exchange | 2.17e-04 | 5 | 88 | 2 | IPR001717 | |
| Domain | CH | 2.50e-04 | 65 | 88 | 4 | SM00033 | |
| Domain | CH | 3.33e-04 | 70 | 88 | 4 | PF00307 | |
| Domain | IQ | 3.51e-04 | 71 | 88 | 4 | PF00612 | |
| Domain | - | 3.51e-04 | 71 | 88 | 4 | 1.10.418.10 | |
| Domain | CH | 3.91e-04 | 73 | 88 | 4 | PS50021 | |
| Domain | CH-domain | 4.33e-04 | 75 | 88 | 4 | IPR001715 | |
| Domain | ANION_EXCHANGER_2 | 4.54e-04 | 7 | 88 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 4.54e-04 | 7 | 88 | 2 | PS00219 | |
| Domain | IQ | 5.81e-04 | 81 | 88 | 4 | SM00015 | |
| Domain | Band3_cytoplasmic_dom | 7.73e-04 | 9 | 88 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 7.73e-04 | 9 | 88 | 2 | PF07565 | |
| Domain | - | 7.73e-04 | 9 | 88 | 2 | 3.40.1100.10 | |
| Domain | DUF1220 | 7.73e-04 | 9 | 88 | 2 | SM01148 | |
| Domain | IQ_motif_EF-hand-BS | 8.63e-04 | 90 | 88 | 4 | IPR000048 | |
| Domain | HCO3_cotransp | 9.64e-04 | 10 | 88 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 9.64e-04 | 10 | 88 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 9.64e-04 | 10 | 88 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 9.64e-04 | 10 | 88 | 2 | IPR003020 | |
| Domain | IQ | 9.76e-04 | 93 | 88 | 4 | PS50096 | |
| Domain | NBPF_dom | 1.17e-03 | 11 | 88 | 2 | IPR010630 | |
| Domain | NBPF | 1.17e-03 | 11 | 88 | 2 | PS51316 | |
| Domain | DUF1220 | 1.17e-03 | 11 | 88 | 2 | PF06758 | |
| Domain | RasGAP | 1.93e-03 | 14 | 88 | 2 | SM00323 | |
| Domain | RasGAP_CS | 1.93e-03 | 14 | 88 | 2 | IPR023152 | |
| Domain | RasGAP | 2.21e-03 | 15 | 88 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.21e-03 | 15 | 88 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.21e-03 | 15 | 88 | 2 | PS50018 | |
| Domain | - | 2.52e-03 | 16 | 88 | 2 | 1.10.506.10 | |
| Domain | RasGAP_dom | 3.20e-03 | 18 | 88 | 2 | IPR001936 | |
| Domain | Myosin-like_IQ_dom | 3.56e-03 | 19 | 88 | 2 | IPR027401 | |
| Domain | - | 3.56e-03 | 19 | 88 | 2 | 4.10.270.10 | |
| Pubmed | MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1. | 7.38e-06 | 2 | 95 | 2 | 31431460 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 33173433 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17563371 | ||
| Pubmed | The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1. | 7.38e-06 | 2 | 95 | 2 | 33743960 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17928512 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29803224 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16964379 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 11682618 | ||
| Pubmed | PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines. | 2.21e-05 | 3 | 95 | 2 | 17652795 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 33173537 | ||
| Pubmed | PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression. | 2.21e-05 | 3 | 95 | 2 | 37159932 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 24395789 | ||
| Pubmed | The lifespan quantitative trait locus gene Securin controls hematopoietic progenitor cell function. | 2.21e-05 | 3 | 95 | 2 | 31073078 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 34262048 | ||
| Pubmed | Pituitary tumor transforming gene as a novel regulatory factor of liver fibrosis. | 2.21e-05 | 3 | 95 | 2 | 25936962 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 25722290 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 16322543 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 36737842 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 17626243 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 15281346 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 20153804 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 22493426 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 18639540 | ||
| Pubmed | Pituitary tumor transforming gene (PTTG) transforming and transactivation activity. | 2.21e-05 | 3 | 95 | 2 | 10713046 | |
| Pubmed | Involvement of IQGAP family proteins in the regulation of mammalian cell cytokinesis. | 2.21e-05 | 3 | 95 | 2 | 25229330 | |
| Pubmed | Aromatase, CYP1B1 and fatty acid synthase expression in breast tumors of BRCA1 mutation carriers. | 2.21e-05 | 3 | 95 | 2 | 19083124 | |
| Pubmed | Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders. | 2.21e-05 | 3 | 95 | 2 | 36930595 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 12626748 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 28516917 | ||
| Pubmed | Sex-steroid milieu determines diabetes rescue in pttg-null mice. | 2.21e-05 | 3 | 95 | 2 | 16731783 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 16959877 | ||
| Pubmed | Characterization of the murine pituitary tumor transforming gene (PTTG) and its promoter. | 2.21e-05 | 3 | 95 | 2 | 10650958 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 23867215 | ||
| Pubmed | Characterization of the pituitary tumor transforming gene 1 knockout mouse retina. | 2.21e-05 | 3 | 95 | 2 | 21203837 | |
| Pubmed | Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. | 2.21e-05 | 3 | 95 | 2 | 17065388 | |
| Pubmed | 2.53e-05 | 21 | 95 | 3 | 16079250 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | BLK SMG1 BRAF MAP4K3 RALBP1 CIBAR2 TIMM29 MAPK6 GNL1 DARS2 AXIN1 | 3.91e-05 | 910 | 95 | 11 | 36736316 |
| Pubmed | Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis. | 4.41e-05 | 4 | 95 | 2 | 15919720 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 22342753 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16030258 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16720305 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 17127711 | ||
| Pubmed | Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene. | 4.41e-05 | 4 | 95 | 2 | 20116377 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 23677169 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 14592810 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 19124608 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 19477929 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 35050550 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 11516952 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 28970065 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 23164239 | ||
| Pubmed | Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. | 4.41e-05 | 4 | 95 | 2 | 23861251 | |
| Pubmed | Spatial learning and long-term memory impairments in RasGrf1 KO, Pttg1 KO, and double KO mice. | 4.41e-05 | 4 | 95 | 2 | 30259712 | |
| Pubmed | Expression of PTTG and prc1 genes during telencephalic neurogenesis. | 4.41e-05 | 4 | 95 | 2 | 10727870 | |
| Pubmed | Pituitary tumor-transforming gene 1 regulates the patterning of retinal mosaics. | 4.41e-05 | 4 | 95 | 2 | 24927528 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16533944 | ||
| Pubmed | Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression. | 4.41e-05 | 4 | 95 | 2 | 16533945 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 17039256 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 25421944 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 17234588 | ||
| Pubmed | Homologue disjunction in mouse oocytes requires proteolysis of securin and cyclin B1. | 4.41e-05 | 4 | 95 | 2 | 14593421 | |
| Pubmed | Securin regulates entry into M-phase by modulating the stability of cyclin B. | 4.41e-05 | 4 | 95 | 2 | 18364698 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 18417614 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 23500099 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 18981426 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 39093409 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 21156286 | ||
| Pubmed | PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8. | 7.34e-05 | 5 | 95 | 2 | 22535767 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 28658604 | ||
| Pubmed | Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. | 7.34e-05 | 5 | 95 | 2 | 17975001 | |
| Pubmed | The meiosis I-to-meiosis II transition in mouse oocytes requires separase activity. | 7.34e-05 | 5 | 95 | 2 | 14561405 | |
| Pubmed | The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation. | 7.34e-05 | 5 | 95 | 2 | 16355229 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 21076990 | ||
| Pubmed | 1.05e-04 | 272 | 95 | 6 | 31010829 | ||
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 33181265 | ||
| Pubmed | Early Hearing Loss upon Disruption of Slc4a10 in C57BL/6 Mice. | 1.10e-04 | 6 | 95 | 2 | 31001720 | |
| Pubmed | mTOR promotes pituitary tumor development through activation of PTTG1. | 1.10e-04 | 6 | 95 | 2 | 27524416 | |
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 21991377 | ||
| Pubmed | Proteotyping of knockout mouse strains reveals sex- and strain-specific signatures in blood plasma. | 1.11e-04 | 34 | 95 | 3 | 34050187 | |
| Pubmed | Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. | 1.54e-04 | 7 | 95 | 2 | 20062064 | |
| Pubmed | Loss of Cdc20 causes a securin-dependent metaphase arrest in two-cell mouse embryos. | 1.54e-04 | 7 | 95 | 2 | 17325031 | |
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 18567582 | ||
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 2.16e-04 | 442 | 95 | 7 | 15815621 | |
| Pubmed | Identification of disease-relevant modulators of the SHH pathway in the developing brain. | 2.62e-04 | 9 | 95 | 2 | 34463328 | |
| Pubmed | Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. | 3.28e-04 | 10 | 95 | 2 | 26731471 | |
| Pubmed | 3.91e-04 | 225 | 95 | 5 | 12168954 | ||
| Pubmed | Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. | 4.00e-04 | 11 | 95 | 2 | 21068098 | |
| Pubmed | Identification of additional transcripts in the Williams-Beuren syndrome critical region. | 4.00e-04 | 11 | 95 | 2 | 12073013 | |
| Pubmed | 4.00e-04 | 11 | 95 | 2 | 21494564 | ||
| Pubmed | 4.00e-04 | 11 | 95 | 2 | 11707776 | ||
| Pubmed | 4.37e-04 | 497 | 95 | 7 | 23414517 | ||
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 4.79e-04 | 12 | 95 | 2 | 27824329 | |
| Pubmed | 4.79e-04 | 12 | 95 | 2 | 21705333 | ||
| Pubmed | IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. | 4.79e-04 | 12 | 95 | 2 | 18604197 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 5.56e-04 | 137 | 95 | 4 | 37039823 | |
| Pubmed | 5.65e-04 | 13 | 95 | 2 | 22294699 | ||
| Pubmed | A genome-wide association study for reading and language abilities in two population cohorts. | 5.65e-04 | 13 | 95 | 2 | 23738518 | |
| Pubmed | 5.65e-04 | 13 | 95 | 2 | 15237213 | ||
| Pubmed | Specificity and Redundancy of Profilin 1 and 2 Function in Brain Development and Neuronal Structure. | 5.65e-04 | 13 | 95 | 2 | 34571959 | |
| Pubmed | 5.65e-04 | 13 | 95 | 2 | 19213844 | ||
| Cytoband | 1p13.3 | 4.07e-04 | 69 | 95 | 3 | 1p13.3 | |
| Cytoband | 16q24 | 5.65e-04 | 17 | 95 | 2 | 16q24 | |
| GeneFamily | Neuroblastoma breakpoint family | 6.79e-05 | 23 | 63 | 3 | 662 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-08 | 199 | 95 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 1.06e-06 | 156 | 95 | 6 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-06 | 174 | 95 | 6 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 2.21e-06 | 177 | 95 | 6 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 184 | 95 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-06 | 192 | 95 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.87e-06 | 195 | 95 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-06 | 196 | 95 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.11e-06 | 197 | 95 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive|Influenza_Severe / Disease, condition lineage and cell class | 4.48e-06 | 200 | 95 | 6 | 0382f8fc27d18003761725e714beb6b3f3150057 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.44e-05 | 144 | 95 | 5 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.25e-05 | 158 | 95 | 5 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-Treg|Int-URO / Disease, Lineage and Cell Type | 2.25e-05 | 158 | 95 | 5 | 457d64dceedb67bfff1303334cda1253a839b3d6 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.54e-05 | 162 | 95 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.54e-05 | 162 | 95 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.85e-05 | 166 | 95 | 5 | 30a180b67572c3f4fb3a291f271f855e1b20005e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.29e-05 | 171 | 95 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.29e-05 | 171 | 95 | 5 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 174 | 95 | 5 | e2243f1e48e3275753a2b3a69d06eefce69a8ded | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.57e-05 | 174 | 95 | 5 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-05 | 177 | 95 | 5 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-05 | 177 | 95 | 5 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.09e-05 | 179 | 95 | 5 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 180 | 95 | 5 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.54e-05 | 183 | 95 | 5 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-05 | 183 | 95 | 5 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-05 | 185 | 95 | 5 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.78e-05 | 185 | 95 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 185 | 95 | 5 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-05 | 185 | 95 | 5 | 68edb1bb03ed221d49e583123ca4de14252d7bc5 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-05 | 186 | 95 | 5 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 187 | 95 | 5 | c10d6a774b3e83f64e47b9ad08f5d6b0dc60d163 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.03e-05 | 187 | 95 | 5 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.16e-05 | 188 | 95 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 5.16e-05 | 188 | 95 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 5.29e-05 | 189 | 95 | 5 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.43e-05 | 190 | 95 | 5 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.43e-05 | 190 | 95 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 191 | 95 | 5 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 191 | 95 | 5 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.56e-05 | 191 | 95 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 5.56e-05 | 191 | 95 | 5 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-05 | 192 | 95 | 5 | a8b7c539dc3037071bf068f372e4215563e11de4 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.70e-05 | 192 | 95 | 5 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 5.70e-05 | 192 | 95 | 5 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 192 | 95 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-05 | 192 | 95 | 5 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-05 | 192 | 95 | 5 | 904c003c4f73b1dfc8243cee02aad2676c515e50 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.84e-05 | 193 | 95 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.99e-05 | 194 | 95 | 5 | 87604c93d20f9171e0a1279bdb6ad73fe5fed356 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.99e-05 | 194 | 95 | 5 | e9c907b8ec4329946338cca5ce8e954fa2cec37b | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 6.14e-05 | 195 | 95 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 6.14e-05 | 195 | 95 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.14e-05 | 195 | 95 | 5 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.29e-05 | 196 | 95 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 6.44e-05 | 197 | 95 | 5 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 95 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.60e-05 | 198 | 95 | 5 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 95 | 5 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.75e-05 | 199 | 95 | 5 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.75e-05 | 199 | 95 | 5 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 6.75e-05 | 199 | 95 | 5 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | (5)_Fibroblast-A_(Fibroblast_progenitors)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.75e-05 | 199 | 95 | 5 | b783917fe0a9725a680aa430a42f02ce294900ef | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.75e-05 | 199 | 95 | 5 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-05 | 199 | 95 | 5 | b877c1d24357249781032e99d4237f72789cc9b8 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.75e-05 | 199 | 95 | 5 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 6.75e-05 | 199 | 95 | 5 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.75e-05 | 199 | 95 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 6.75e-05 | 199 | 95 | 5 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-05 | 199 | 95 | 5 | e32fa66f3361474088ba1dd58574822537950d59 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.75e-05 | 199 | 95 | 5 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.92e-05 | 200 | 95 | 5 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.92e-05 | 200 | 95 | 5 | 28e5354008adf97b17333f17f8cbef930db6729a | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.92e-05 | 200 | 95 | 5 | c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.92e-05 | 200 | 95 | 5 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.92e-05 | 200 | 95 | 5 | 14f3fe19b6647b32a5e28d717235741997d8522c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.92e-05 | 200 | 95 | 5 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.92e-05 | 200 | 95 | 5 | 25d3865aa2ced11a5ed40013e83b47d942fdf582 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.92e-05 | 200 | 95 | 5 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.92e-05 | 200 | 95 | 5 | 56536236a7012efdb28f85b40e464f3da3e87ce8 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 116 | 95 | 4 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | VE-CD4-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 1.68e-04 | 129 | 95 | 4 | e89d414e1b23e1656747defa39f09b51944a2166 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-04 | 132 | 95 | 4 | c07842a4b514f1e950c8af303f3b6b4275906e6a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.30e-04 | 140 | 95 | 4 | 7b359bfbd404ab06d799048252f4985d85852048 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Fos_(Layer_2/3,_IEG+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 56 | 95 | 3 | a6a0345ddb9db1441fc048bc4d7b05f625de2ccd | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tshz2-Nrep_(Subiculum_and_Entorhinal_Cortex)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 56 | 95 | 3 | 7b7aaa514a3e85250d6279e0770a9409c4b0b199 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tshz2-Nrep_(Subiculum_and_Entorhinal_Cortex)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 56 | 95 | 3 | 17c37bdd1f9733c3823e98ed4d1cd0ca9db66e9c | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 2.91e-04 | 149 | 95 | 4 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 2.91e-04 | 149 | 95 | 4 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.46e-04 | 156 | 95 | 4 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| Disease | age at first sexual intercourse measurement | 1.51e-04 | 383 | 88 | 7 | EFO_0009749 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 2.43e-04 | 8 | 88 | 2 | EFO_0008309 | |
| Disease | frontal fibrosing alopecia | 4.02e-04 | 48 | 88 | 3 | EFO_0009855 | |
| Disease | T wave morphology measurement | 7.82e-04 | 14 | 88 | 2 | EFO_0008398 | |
| Disease | Asbestosis | 7.82e-04 | 14 | 88 | 2 | C0003949 | |
| Disease | Pulmonary Fibrosis - from Asbestos Exposure | 7.82e-04 | 14 | 88 | 2 | C2930617 | |
| Disease | anemia (implicated_via_orthology) | 9.00e-04 | 15 | 88 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Romano-Ward Syndrome | 1.03e-03 | 16 | 88 | 2 | C0035828 | |
| Disease | Adenocarcinoma of prostate | 1.61e-03 | 20 | 88 | 2 | C0007112 | |
| Disease | platelet crit | 2.14e-03 | 952 | 88 | 9 | EFO_0007985 | |
| Disease | Depressive Symptoms | 2.73e-03 | 26 | 88 | 2 | C0086132 | |
| Disease | Neurodevelopmental Disorders | 2.74e-03 | 93 | 88 | 3 | C1535926 | |
| Disease | Ischemic stroke | 2.88e-03 | 324 | 88 | 5 | HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDLSPDHPVVLENHV | 16 | Q8N9N5 | |
| EHHPIPQEEASLAET | 296 | P15056 | |
| LFLHDVDLLPENDHN | 191 | O60512 | |
| VQLSRANEDPEHPHA | 256 | Q6ZTR7 | |
| EETHVEAREHQPEPE | 211 | Q8IUX7 | |
| HLHFDQGPLVEPAAD | 506 | Q9NVE4 | |
| ALEADTFPDEIHHPK | 606 | Q9Y222 | |
| DHQDAIAPEHNDPIH | 1311 | P46940 | |
| IAPEHNDPIHELLDD | 1316 | P46940 | |
| SEHPHDEEEEALNIP | 246 | Q96M43 | |
| HDILHEPPDVVSDDE | 51 | Q15311 | |
| HNEDIHFEPIVSLPE | 2906 | P49792 | |
| HEQDIRAEQPVEPHD | 451 | Q7Z6P3 | |
| PELLVFPAQTDLHEH | 186 | Q96P11 | |
| DEIFDQIPELLEHHE | 1111 | Q96PE2 | |
| LIERIPDENGHDHAE | 3546 | Q01484 | |
| VPHPDSQPDTIDHDL | 101 | P00746 | |
| QQHIPETHNDLPEEL | 766 | Q8N7Z5 | |
| DLREFPGDLPEHTNH | 86 | Q7Z5L7 | |
| TEPHHELPDSDGFLD | 346 | Q8IVH8 | |
| EDVDLHLFLPDCHPS | 586 | Q2LD37 | |
| PISSHPFHIEDEVDD | 326 | Q16659 | |
| DEHQHVPEDPREKSQ | 441 | Q2TBE0 | |
| PSEDHLEEFIAEHLP | 76 | Q9UHL3 | |
| ELDHDAPPENHTICV | 86 | O60928 | |
| LQELATHLHPAEPEE | 266 | Q96KN1 | |
| HLLQAPASHEDLDAP | 141 | Q9ULI4 | |
| LLHLRHPEAEDPSAE | 456 | P36915 | |
| LLEPEPEEDASHAHP | 251 | A5LHX3 | |
| ENGSDRDPLHPEHLS | 301 | O75081 | |
| APDHQDPLHELLEDL | 1301 | Q86VI3 | |
| HDLPMDEHVLPDDAD | 141 | Q96JM4 | |
| DSDDSPLLDDFHVHP | 106 | Q6V1P9 | |
| DDNDDGHPLHPSLNI | 26 | Q6MZM9 | |
| VGQAEHLEEEHDPSP | 351 | O00461 | |
| ELSADFEHQAPPRDH | 681 | Q5VYJ5 | |
| EELHLLHFPNSPEEN | 51 | Q96M78 | |
| EDPLEDPHLHLNIEE | 101 | Q5T4I8 | |
| EELHEAVKHIAEDPP | 211 | Q86XJ1 | |
| PPDEHLDEDKHFVVA | 51 | P51451 | |
| DAHEENPESILDEHV | 461 | O15169 | |
| DLLQDTSHLPPEHSD | 51 | Q96CU9 | |
| DIDNHFIELPEDLPQ | 386 | Q6IQ26 | |
| HAVDVVLDPDTAHPD | 326 | Q7KYR7 | |
| NPHAEAHEAIFDLDL | 61 | Q6UXX5 | |
| DGDPHFVIQIPHSEE | 1081 | Q6UXX5 | |
| ESAVHEPLHIEAEDP | 511 | Q8IXH8 | |
| HAPEDPSDLLQHVKF | 16 | Q8N6P7 | |
| AHELPLDAHVLEPDE | 566 | Q8WUQ7 | |
| RGIHDHLPDFQDSEE | 56 | Q9BZB8 | |
| HDDPEFRELLSHNEE | 216 | Q16678 | |
| DDGHDLRIPLHNEDA | 11 | O75052 | |
| HFLLEEDKPEEPTAH | 1516 | P49327 | |
| IHSHAQPPDAREEDI | 591 | Q6P995 | |
| EELHHQIPFIPSEDS | 841 | Q56UN5 | |
| DHLEEFIAEHLPEAS | 156 | P0C7A2 | |
| EDTLGHVLSPEPDHD | 96 | Q96NZ9 | |
| ESFDLPEEHQIAHLP | 126 | O95997 | |
| HEHPLTSELDPEKEQ | 411 | Q96PC5 | |
| ELLFDPDDEHSEPVH | 206 | Q96P20 | |
| QLAFHVQDDHDPPNL | 671 | P0C091 | |
| VCTPEAHEPDKEDNH | 796 | P84550 | |
| EENPRELESAHHPFT | 491 | Q6PI48 | |
| FILGTEDDDEEHIPH | 96 | Q9Y6M7 | |
| LNFDDPLNIEAAEHH | 151 | Q969M7 | |
| AEHEDELPEHFKPSQ | 416 | O75151 | |
| DCDINDDEFLHLPAH | 181 | Q9BSF4 | |
| AQSEDPLPELHEDLH | 5831 | Q8WXH0 | |
| PLPELHEDLHNEKEL | 5836 | Q8WXH0 | |
| SEHPHDEEEEALNIP | 246 | Q86XG9 | |
| SEHPHDEEEEALNIP | 246 | Q5VWK0 | |
| QIPLDEDDPRLHLSH | 1761 | Q96Q15 | |
| ESFDLPEEHQIAHLP | 126 | Q9NZH4 | |
| TIDAIPDHHPGEEIF | 731 | Q8IX21 | |
| HLSDLAPLLLHPEEE | 606 | Q6P9B9 | |
| NNASPHFEPDLHIED | 1051 | Q9UPV0 | |
| EHEHELSPGVFENVP | 541 | Q8NHH1 | |
| ALADEDHSLHPPLQR | 911 | Q8IZQ1 | |
| KQHQDSRLEPEPHEE | 1296 | Q6ZVD8 | |
| EEEENPVHKIPDSHE | 161 | Q9NW82 | |
| DFPEDLQKHIAECHP | 256 | Q96K83 | |
| FILGTEDDDEEHIPH | 101 | Q6U841 | |
| LPEHHEAFNRLLEDP | 151 | Q8NFV5 | |
| HRELLHPSPNQDSEE | 26 | O15015 | |
| PVEAEAAPHTDQDHV | 541 | O15015 | |
| FDSDIPLHSGNDHPE | 831 | Q9HCK1 | |
| PELEEELEADHTPHY | 546 | P28908 | |
| DETHDPKLQHLAPEE | 1801 | O95359 | |
| HEDEEPAFPHTELAN | 61 | O00507 | |
| EVDEEHVHRANPPEL | 556 | Q8IUG5 | |
| HVHRANPPELDQVED | 561 | Q8IUG5 | |
| HDDPLEPHQGNQEKL | 251 | Q9NZV7 | |
| HAHLDPENKLEFEPD | 576 | Q9ULD9 | |
| EEESDGLPAFHLPLH | 41 | P35711 | |
| PHDPVALEEHFRDDD | 46 | Q9UH65 | |
| HLKEQHPDIENPDLA | 1791 | Q9C0G0 | |
| EEPPLLEELGIHFDH | 111 | Q8N8F6 | |
| EEDELYLLDPEHAHP | 546 | Q96S15 | |
| DQDFPLHPRENDQLD | 286 | Q9C040 | |
| LPPQALIEHHEEAEE | 151 | Q9H9Y6 | |
| LEHIQQHPEEPLEGT | 71 | Q8N6I4 | |
| DEIHSPAHPEIEKAD | 71 | Q9BS31 |